Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01427556 · ClinicalTrials.gov registry record

The Hormonal and Behavioral Impact of Eating Breakfast

A clinical trial, sponsored by USDA, Western Human Nutrition Research Center.

Completed
Registry status
120
Enrollment target

NCT01427556: Completed study, sponsored by USDA, Western Human Nutrition Research Center.

NCT01427556 is a clinical trial that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01427556 has completed, sponsored by USDA, Western Human Nutrition Research Center.

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

This study is exploring the relationship between food intake behavior and the hypothalamic-pituitary axis (HPA) in women who regularly skip breakfast compared to women who regularly eat breakfast.

Primary Outcome

The goal is to explore the relationship between food intake behavior and the hypothalamic-pituitary axis (HPA) in a group of women who regularly skip breakfast and in another group of women who regularly eat breakfast.

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-08
Est. Completion 2014-08

What the finished NCT01427556 record still lists

NCT01427556 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01427556 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01427556 about?

NCT01427556 is a clinical study titled "The Hormonal and Behavioral Impact of Eating Breakfast". This study is exploring the relationship between food intake behavior and the hypothalamic-pituitary axis (HPA) in women who regularly skip breakfast compared to women who regularly eat breakfast.

What is the current status of trial NCT01427556?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2009-08. Estimated completion is 2014-08.

Who is sponsoring clinical trial NCT01427556?

This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01427556, the US trial registry maintained by the National Library of Medicine. NCT01427556 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.